Human thymopoiesis produces polyspecific CD8<sup>+</sup> α/β T cells responding to multiple viral antigens.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 36995951.
- Also identified by DOI 10.7554/eLife.81274 and PMC identifier 10063231.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
T-cell receptors (TCRs) are formed by stochastic gene rearrangements, theoretically generating >10<sup>19</sup> sequences. They are selected during thymopoiesis, which releases a repertoire of about 10<sup>8</sup> unique TCRs per individual. How evolution shaped a process that produces TCRs that can effectively handle a countless and evolving set of infectious agents is a central question of immunology. The paradigm is that a diverse enough repertoire of TCRs should always provide a proper, though rare, specificity for any given need. Expansion of such rare T cells would provide enough fighters for an effective immune response and enough antigen-experienced cells for memory. We show here that human thymopoiesis releases a large population of clustered CD8<sup>+</sup> T cells harboring α/β paired TCRs that (i) have high generation probabilities and (ii) a preferential usage of some V and J genes, (iii) which CDR3 are shared between individuals, and (iv) can each bind and be activated by multiple unrelated viral peptides, notably from EBV, CMV, and influenza. These polyspecific T cells may represent a first line of defense that is mobilized in response to infections before a more specific response subsequently ensures viral elimination. Our results support an evolutionary selection of polyspecific α/β TCRs for broad antiviral responses and heterologous immunity.
Medical subject headings
- CD8-Positive T-Lymphocytes
- Antigens, Viral